Picture of RaySearch Laboratories AB (publ) logo

RAY B RaySearch Laboratories AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for RaySearch Laboratories AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.48-58.732.4110263
Non-Cash Items206244282284248
Other Non-Cash Items
Changes in Working Capital13252.5661.4-25.3
Change in Accounts Receivable
Change in Other Liabilities
Cash from Operating Activities332238321456485
Capital Expenditures-226-255-201-209-218
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items17.6
Other Investing Cash Flow
Cash from Investing Activities-226-238-201-209-218
Financing Cash Flow Items21.3-21.30
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-44-72.2-72.5-56.4-160
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash54.9-66.257.7183119